17 June 2021 - Deborah Wilkes
Premium
German consumer healthcare company PharmaSGP is acquiring a portfolio of four OTC brands in eight countries from GlaxoSmithKline (GSK) for around EUR80 million (USD95.5 million).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.